baber/WOPTO huggingface dataset:
Patent AU-2002303211-B2 (AU)
Title: Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
Inventor: WANG CHANG YI
IPC: A61P25/28
Filed: 2002-04-02
Granted: 2008-02-28
Abstract: The present invention relates to a composition comprsing a peptide immunogen useful for the prevention and treatment of Alzheimer's Disease. More particularly, the peptide immunogen comprises a main functional/regulatory site, an N-terminal fragment of Amyloid ² (A²) peptide linked to a helper T cell epitope (Th) having multiple class II MHC binding motifs. The peptide immunogen elicit a site-directed immune response against the main functional/regulatory site of the A² peptide and generate antibodies, which are highly cross-reactive to the soluble A² 1-42  peptide and the amyloid plaques formed in the brain of Alzheimer's Disease patients. The antibodies elicited being cross reactive to the soluble A² 1-42  peptide, promote fibril disaggregation and inhibit fibrillar aggregation leading to immunoneutralization of the "soluble A² - derived toxins"; and being cross-reactive to the amyloid plaques, accelerate the clearance of these plaques from the brain. Thus, the composition of the invention comprising the peptide immunogen is useful for the prevention and treatment of Alzheimer's Disease.
Patent AU-2002305769-B2 (AU)
Title: Small molecule antagonists of Bcl2 family proteins
Inventor: YANG DAJUN
IPC: A61P43/00
Filed: 2002-05-30
Granted: 2007-07-19
Abstract: The present invention relates to naturally occurring and chemically synthesized small molecules antagonists of Bcl-2 family proteins. In particular, the present invention provides gossypol derivatives and methods of using gossypol derivatives as antagonists of the anti-apoptotic effects of Bcl-2 and Bcl-XL proteins especially in cancer cells that overexpress Bcl-2 family proteins (e.g., Bcl-2 and/or Bcl-XL).
Patent AU-2002308722-B2 (AU)
Title: Anti-NGF antibodies for the treatment of various disorders
Inventor: SHELTON DAVID L
IPC: A61P25/00
Filed: 2002-05-09
Granted: 2007-05-17
Abstract: The present invention relates generally to methods of using anti-NGF antibodies in the treatment of various NGF-related disorders. The methods are effective in treating these disorders in a patient without having a significant adverse effect on the immune system of the patient.
Patent AU-2002315123-B2 (AU)
Title: Methods and apparatus for customizing pet food
Inventor: MARTINEAU BRIGITTE
IPC: G06Q30/06
Filed: 2002-06-13
Granted: 2008-06-05
Abstract: A method for creating a customized pet food additive formula for a pet includes receiving, through an electronic interface, a user input including an individual pet profile for the pet, receiving an analysis from a biological sample of the pet, and electronically processing the individual pet profile and the biological sample analysis to create a pet food additive formula utilizing information obtained from the user input individual pet profile and the biological sample analysis.
Patent AU-2003205905-B2 (AU)
Title: Apparatus for marking a vehicle using a laser beam
Inventor: BELL JOHN THOMAS
IPC: B23K26/42
Filed: 2003-02-21
Granted: 2009-01-29
Abstract: The present invention provides a method and apparatus for marking vehicles using a laser. In order to allow any part of the vehicle to be marked using a simple, strong laser beam delivery conduit, the laser is mounted on a structure 101 which extends over a vehicle station 102. The structure defines at least three laser mounting positions and preferably four laser mounting positions A, B, C, D, spaced apart from one another in two dimensions for mounting at least one laser apparatus 107. The laser apparatus 107comprises a laser emitter 108 for producing a laser beam adapted to mark a part of the vehicle and laser beam delivery means 110 for delivering a laser beam from the laser emitter 108 to a selectable point of the vehicle station 102. The laser apparatus 107 is movable between at least two and preferably all four of the laser mounting positions A, B, C, and D. <IMAGE>
Patent AU-2004274487-B2 (AU)
Title: KID3 and KID3 antibodies that bind thereto
Inventor: LIANG TONY W
IPC: C07K/
Filed: 2004-09-17
Granted: 2011-09-01
Abstract: The invention provides the identification and characterization of disease and cancer-associated epitope, KID3. The invention also provides a family of monoclonal antibodies that bind to KID3, methods of diagnosing and treating various human cancers and diseases that express KID3.
Patent AU-2004299860-B2 (AU)
Title: Coating compositions with enhanced corrosion resistance and appearance
Inventor: SCHNEIDER JOHN R
IPC: C09D7/61
Filed: 2004-12-15
Granted: 2007-11-15
Abstract: Coating compositions having improved corrosion resistance are disclosed. The coatings comprise high levels of particles having particle size and surface area sufficient to provide the desired level of corrosion resistance. The improved resistance is achieved without adversely affecting the appearance of the coatings. Methods of using the coatings, and the substrates coated therewith, are also disclosed.
Patent AU-2004316497-B2 (AU)
Title: Transmission and constant speed accessory drive
Inventor: ALI IMTIAZ
IPC: F16H61/662
Filed: 2004-08-02
Granted: 2009-07-30
Abstract: An infinitely variable speed ratio planetary ball transmission comprising planetary members in rolling contact with moveable inner and outer races and a constant speed accessory drive system utilizing the transmission. The transmission is infinitely variable between ratios of approximately 0.3 and 1.0. A transmission input shaft is connected to a prime mover such as a vehicle engine crankshaft by a drive belt. The transmission comprises at least one output shaft that is coaxial with the input shaft. An output pulley is attached to the output shaft. A belt is engaged between the output pulley and various engine accessories. A second end of the transmission output shaft may be directly coupled to an engine accessory mounted on the transmission. An included control system senses a crankshaft speed. A processor analyses the crankshaft speed and accordingly adjusts the transmission ratio using a stepper motor connected to a worm drive to maintain a constant output speed regardless of crankshaft speed.
Patent AU-2004321585-B2 (AU)
Title: Treatment of neurological disorders with hematopoeitic growth factors
Inventor: GASSLER NIKOLAUS
IPC: A61K38/20
Filed: 2004-12-29
Granted: 2011-02-03
Abstract: The present invention relates to a method of treating a neurological condition such as glaucoma in a mammal by administering at least one hematopoietic growth factor such as G-CSF or a polynucleotide encoding for G-CSF.
Patent AU-2004323808-B2 (AU)
Title: Process for producing mycophenolic acid using penicillium arenicola BICC 7673
Inventor: DEVI SHARMA PINAKEE
IPC: C12P17/04
Filed: 2004-10-05
Granted: 2011-11-17
Abstract: The present invention discloses the manufacture of MPA by fermentation under optimal fermentation parameters using a new strain of
Patent AU-2005206628-B2 (AU)
Title: Sampling and assay device
Inventor: ESA ROSMAN
IPC: B65D81/32
Filed: 2005-01-19
Granted: 2011-07-07
Abstract: A sampling and assay device comprises at least three chamber portions (1, 3, 4) connected together in a row. Each chamber portion (1, 3, 4) defines a chamber (11, 13, 27) and adjacent chambers (11, 13, 27) along the row are separated by respective partitions (14, 15). One end chamber (4) is capable of receiving a sample either on a swab or as a liquid. The other chambers (11, 13) contain reagent for performing the assay. Adjacent chamber portions (1, 3, 4) along the row are relatively movable towards each another. In respect of each pair of adjacent chamber portions (1, 3), one of the adjacent chamber portions (1) has the respective partition (14) fixed thereto and the other of the adjacent chamber portions (3) has a rupture member (17) arranged to rupture the respective partition (14) on relative movement of the adjacent chamber portions (1, 3). As a result, the sampling and assay device is capable of rupturing each partition (14, 15) simultaneously on relative movement of the chamber portions (1, 4) at the ends of the row towards each other. Also, each pair of adjacent chamber portions (1, 3) have respective connection portions (2a, 3a) mated together, the connection portions (2a, 3a) being designed to allow further chamber portions identical to an intermediate chamber portion to be connected into said row.
Patent AU-2005246363-B2 (AU)
Title: System and method for disseminating color ink and colorant formulas
Inventor: DANNY RICH
IPC: G06F17/30
Filed: 2005-05-20
Granted: 2011-08-04
Abstract: The present invention provides a plurality of representations of color that are stored in an electronic color library and that can be selected by a user. After a color selection is made, a plurality of color ink formulas and/or colorant formulas capable of producing the selected color are provided. Further, other selections can be made to define a substrate or other criteria that can impact the color ink formulas. The user can make a selection among the plurality of color ink formulas and/or colorant formulas. The selected color ink formulas) (or colorant formula(s)) can be transmitted over a communication network, such as the Internet or a local Intranet to another party, such as an ink manufacturer.
Patent AU-2005265098-B2 (AU)
Title: TDF-related compounds and analogs thereof
Inventor: SWORIN MICHAEL
IPC: C12N15/00
Filed: 2005-06-17
Granted: 2012-02-23
Abstract: The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing , and treating TDF-associated disorders.
Patent AU-2005265224-B2 (AU)
Title: ACACs as modifiers of the IGF pathway and methods of use
Inventor: LYNN BJERKE
IPC: C12Q1/18
Filed: 2005-06-20
Granted: 2011-09-29
Abstract: Human ACAC genes are identified as modulators of the IGF pathway, and thus are therapeutic targets for disorders associated with defective IGF function. Methods for identifying modulators of IGF, comprising screening for agents that modulate the activity of ACAC are provided.
Patent AU-2005268406-B2 (AU)
Title: Scissors with slide cutting
Inventor: TELLINI LUIGI
IPC: B26D3/16
Filed: 2005-07-28
Granted: 2009-05-28
Abstract: Scissors comprising a stem ( 1 ) integrally defining a stationary blade ( 3 ) and a stationary handle ( 2 ), a truncated handle ( 6 ) pivotally connected to the stem ( 1 ) around a first rotation pin ( 7 ), and a movable blade ( 5 ) fractured in relation to the truncated handle ( 6 ), the assembly of the movable blade ( 5 ) and the truncated handle ( 6 ) crossing and overlapping with the stem ( 1 ), a cutting line (X) being defined by the line along which the cutting is completed in the closure position of the movable blade ( 6 ). According to the invention, the first rotation pin ( 7 ) is off-centered in relation to the cutting line, on the side of the movable blade ( 5 ), and the movable blade ( 5 ) is supported by the truncated handle ( 6 ) and by the stem ( 1 ) in at least two points via respective purely pivotal connections. Articulated control means ( 9 ) are connected to said movable blade ( 5 ) in correspondence to at least one of said points, for controlling the movement of said movable blade in response to mutual closure between said stationary handle ( 2 ) and said truncated handle ( 6 ).
Patent AU-2005282212-B2 (AU)
Title: Method, material and system for controlled release of anti-microbial agents
Inventor: PARSONS ALLEN ROLAND
IPC: A01N59/16
Filed: 2005-09-07
Granted: 2012-02-09
Abstract: There is provided a method for treating a fluid with an anti-microbial agent comprising the steps of: (a) contacting the fluid with a solid material containing an anti-microbial agent; and, (b) abrading an interface of the solid material and removing particles therefrom and exposing an underlying surface of the solid material to the fluid, thereby facilitating release of the antimicrobial agent of the underlying surface of the solid material and/or the removed particles into the fluid. The solid material comprises an anti-microbial agent dispersed and/or embedded in a solid carrier. Typically, the anti-microbial agent is one or more of a metal, metal oxide, metal compound, metal salt, metal-ligand complex or derivatives thereof based on silver, copper and zinc.
Patent AU-2006202346-B2 (AU)
Title: Methods of pre-selecting a polymerizable fluid formed into an introcular lens
Inventor: WEEBER HENDRIK ALBERT
IPC: A61F2/16
Filed: 2006-06-01
Granted: 2008-09-18
Abstract: The present invention refers to a method of restoring the vision of an eye having an impaired lens with an artificial lens implant. The method involves replacing the lens by a polymerizable material injected into the emptied lens capsule and thereby providing a new lens implant with a predetermined refractive value, while admitting the possibility of controlling and adjusting the refractive value of the eye during the surgical process.
Patent AU-2006247067-B2 (AU)
Title: Methods for diagnosis and treatment of proliferative disorders mediated by CD40 signaling
Inventor: AUKERMAN SHARON LEA
IPC: A61K39/395
Filed: 2006-05-18
Granted: 2012-06-07
Abstract: Methods for identifying subjects having a cancer or pre-malignant condition that will benefit from anti-CD40 therapeutic agents that modulate CD40L-mediated CD40 signaling are provided. The methods comprise the use of biomarkers of cellular apoptosis, cell proliferation and survival, and CD40 signaling pathways to monitor ex vivo response to one or more anti-CD40 therapeutic agents of interest that modulate CD40 signaling on CD40-expressing neoplastic cells. The ex vivo prognostic assays can be used alone or in conjunction with other prognostic assays to identify candidate subjects who will benefit from treatment with anti-CD40 therapeutic agents. Methods of the invention also comprise the use of these biomarkers to monitor in vivo efficacy of treatment with an anti-CD40 therapeutic agent.
Patent AU-2006268987-B2 (AU)
Title: Method for preparing plasticised wheat gluten compositions for petfood and pet treat applications
Inventor: SCHEERLINCKX WIM
IPC: A23K1/18
Filed: 2006-06-30
Granted: 2012-02-16
Abstract: A method for manufacturing plasticised gluten compositions for pet food and pet treat applications, the method comprising the steps of : mixing at least gluten and a plasticiser wherein the mixing equipment is set to a value below 500C and the SME (Specific Mechanical Energy) applied to the mix is less than 600 kj/kg, wherein the gluten content is between 20 and 85% by weight wherein the plasticiser content is less than 40% by weight. The invention also relates to the use of plasticised gluten for the manufacture of a chewy pet food having a high breaking force.
Patent AU-2006275881-B2 (AU)
Title: Stent/graft device and method for open surgical placement
Inventor: DEMETRIADES DEMETRIOS
IPC: A61B17/115
Filed: 2006-07-26
Granted: 2012-04-12
Abstract: A stent/graft device for intraoperative repair of a damaged portion of a body- vessel, comprising a generally cylindrical body having a passageway therethrough; and a connector positioned at least at one axial end of said body, an axial end of said connector extending into said passageway and another axial end of said connector extending from said body, said axial end extending into said passageway having a diameter such that said end is snugly received in said body, said axial end extending from said body including a mechanism for effecting engagement with said vessel and wherein said device comprises a connector positioned at each axial end thereof, aech of said connectors including a portion adapted for fixed engagement with said vessel via one or more sutures .
Patent AU-2006289664-B2 (AU)
Title: Screen panel
Inventor: ANTHONY SPINKS WARREN
IPC: B01D33/333
Filed: 2006-09-07
Granted: 2011-08-04
Abstract: A screening panel module is provided for use in band screens used to remove solid material from a flowing liquid. Each screening panel comprises a frame formed of a plastics material in which a screen element is held. Each screen panel is provided with connection means at opposite ends of the frame. Each of the connection means is arranged to co-operate with complementary connection means of an abutting end of an adjacent panel to provide a pivotable connection there between. When a plurality of such panels is connected, they form an endless band. Each panel frame has an opening extending from one surface to an opposing surface of the panel frame and a screen element is removably fastened over the at least one opening. The screen element has a plurality of holes or apertures formed therein to provide fluid communication through the panel.
Patent AU-2006292042-B2 (AU)
Title: Method for identifying tags using adaptive binary tree splitting technique in RFID system and RFID system therefor
Inventor: SANG-YUN LEE
IPC: G06K17/00
Filed: 2006-09-08
Granted: 2011-10-13
Abstract: The RFID system includes an RFID reader for sending information selected from among collision type information, idle type information, and readable type information, to all of the RFID tags depending on the number of signals in the corresponding time slot, and RFID tags for performing functions, in which, when information, indicating that a current time slot is a collision type, is fed back from the RFID reader, each of RFID tags selects one arbitrary value of either 0 or 1 and is assigned a time slot, in which a corresponding RFID tag will send a signal to the RFID reader, based on the selected value, a single tag group that caused a collision is divided into two sub-groups depending on the assigned time slots, and tags of the sub-groups send signals, including IDs thereof, to the RFID reader in different time slots for the respective sub-groups.
Patent AU-2006321018-B2 (AU)
Title: A method of discovering leakage in a heat exchanger
Inventor: GUSTAFSSON MATS
IPC: G01M3/32
Filed: 2006-11-30
Granted: 2012-05-17
Abstract: The present invention relates to a method of discovering leakage in a heat exchanger (1). The method is carried into effect on an intact heat exchanger (1) which, together with surrounding conduits, is filled with water. The heat exchanger (1) is to have requisite pressure indicators (5-10) mounted between each section (2, 3, 4), as well as requisite shut-off valves (11, 12, 13). The method comprises the steps that, in each section (2, 3, 4) of the heat exchanger (1) an excess pressure is applied on one side and is enclosed there, while the other side is at normal pressure. The pressure is enclosed during a period of time and is monitored during this period of time.
Patent AU-2007209000-B2 (AU)
Title: A phenolic foam board
Inventor: RUUD ZEGGELAAR
IPC: B29C44/32
Filed: 2007-01-30
Granted: 2011-08-18
Abstract: A rigid insulating phenolic foam body (8) has at least one perforated facing (1). The facing (1) is preferably perforated before the facing (1) is adhered to the foam body. The facing (1) may be a gas impermeable material such as a metallic foil. The perforations (5) in the gas impermeable material reduce the drying and curing time, for phenolic foam bodies when compared with phenolic foam bodies with gas permeable facings.
Patent AU-2007250934-B2 (AU)
Title: Ester compound and its use in pest control
Inventor: MORI TATSUYA
IPC: A01N53/00
Filed: 2007-04-27
Granted: 2012-02-09
Abstract: An ester compound represented by the formula (I): has excellent pest controlling activity and is useful as an active ingredient for a pest controlling agent.
Patent AU-2007253822-B2 (AU)
Title: Injection device and method of assembly and activation
Inventor: TANNER II JOHN C
IPC: A61M5/00
Filed: 2007-05-16
Granted: 2013-03-14
Abstract: An injector device for injecting or transferring a pharmaceutical product from a pharmaceutical cartridge. The injector device includes a body having a side wall having a proximal end portion and a distal end portion, the side wall having an inner surface and an outer surface, the inner surface of the side wall defining a space for receiving at least a portion of a body of a pharmaceutical cartridge therein. One or more retention members are disposed on the outer surface of the body. The injector device further includes a plunger rod having a proximal end portion and a distal end portion, the distal end portion of the plunger rod having a connection member constructed for connection to a connecting member mounted on a piston associated with a cartridge. The plunger rod has one or more receiving members formed about its length. The one or more retention members and the one or more receiving members are constructed to cooperatively retain the plunger rod on the body when the plunger rod is in a first position, and are constructed to cooperatively release the plunger rod from the body when the plunger rod is moved toward the distal end of the body to a second position. The plunger rod further includes a surface for engaging a proximal end of a body of a pharmaceutical cartridge positioned within the body of said injector and for moving a proximal end of a body of a pharmaceutical cartridge distally as the plunger rod is moved from its first position to its second position. Movement of the plunger rod from the first position to the second position releases the plunger rod from the body of the injector and simultaneously activates a pharmaceutical cartridge disposed within the body of said injector.
Patent AU-2007275565-B2 (AU)
Title: Medicinal delivery system and related methods
Inventor: SHIFFMAN SAUL M
IPC: A61K9/20
Filed: 2007-07-23
Granted: 2012-07-19
Abstract: A method is provided of making a medicinal delivery system which satiates a craving in an individual when the medicinal delivery system is administered orally to the individual. A coating composition is applied on a saliva-soluble powder to establish a coated powder, the coating composition featuring an at least partially solubilized craving satiation medicinal compound. The coated powder is combined with an edible carrier base to establish a medicinal delivery system that rapidly releases medicine and buffer preferably followed by slower, sustained release.
Patent AU-2007304490-B2 (AU)
Title: Polyethylene composition for pressure pipes with enhanced flexibility
Inventor: HAGSTRAND PER-OLA
IPC: C08L23/04
Filed: 2007-09-28
Granted: 2011-02-17
Abstract: The present invention relates to a polyethylene composition comprising a base resin which comprises 
(a) an ethylene homo- or copolymer fraction (A); and 
(b) an ethylene homo- or copolymer fraction (B),  
wherein 
(i) fraction (A) has a lower weight average molecular weight than fraction (B); 
(ii) the base resin has a density of 932 to 938 kg/m 3 ; 
(iii) the polyethylene composition has an MFR 5  of 0.1 to 0.6 g/10 min ; and 
(iv) the polyethylene composition has a shear stress · 2.7 kPa  of 85 to 230 kPas.  Furthermore, the present invention relates to an article, preferably a pipe comprising said composition and to the use of said composition for the production of an article, preferably a pipe.
Patent AU-2007306102-B2 (AU)
Title: T cell epitope databases
Inventor: BAKER MATTHEW PAUL
IPC: G16B50/10
Filed: 2007-10-11
Granted: 2012-02-23
Abstract: The invention relates to databases of T cell epitopes, especially helper T cell epitopes, for rapid interrogation of protein sequences for the presence of T cell epitopes. The invention includes full or partial databases and data structures of T cell epitopes including epitopes identified especially by ex vivo T cell assays with test peptides and includes T cell epitopes identified by extrapolation of data from test peptides. The present invention also includes high throughput methods for determining the T cell epitope activity of peptides for subsequent inclusion in databases and data structures including methods where subsets of T cells especially regulatory T cells are removed or inhibited from T cell assays in order to maximize the sensitivity of detection of T cell epitope activity.